Erlocip 150mg

Uses
Erlotinib is used to treat metastatic non-small cell lung cancer, as first line treatment,
maintenance treatment, or after failure of one prior chemotherapy. It is also used to treat
locally advanced, unresectable (which cannot be removed by surgery), or metastatic (cancer
which has spread) pancreatic cancer in combination with another drug called gemcitabine.

How it works
Erlotinib belongs to a class of medications called tyrosine kinase inhibitors. It works by
preventing the activity of a protein called epidermal growth factor, and thereby stops the
growth and spread of cancer cells.

Common side effects

dry skin, cough, fatigue, alopecia, nausea, folliculitis, Infection, liver function test abnormalities,
abdominal pain, anorexia, , dyspepsia, vomiting, conjunctivitis, depression, skin fissures., acne,
rigor, pruritus, diarrhea, stomatitis, neuropathy, rash, paronychia, dyspnea, serious lung disease,
headache, gastrointestinal bleeding, weight changes, flatulence

Expert advice
Erlotinib tablets should be taken either 1 hour before or 2 hours after ingestion of food.
Erlotinib is not recommended for children and adolescents under 18 years of age.
Stop smoking and use effective contraceptive measures while on erlotinib treatment.
Do not start erlotinib if you use contact lenses, have had eye problems (ulcers in front part of
eye, dry eyes, inflammation in front part of eye), liver or kidney problems, Gilberts syndrome
(liver disorder that causes increased bilirubin), intolerance to some sugars, are pregnant or
breast-feeding.
Tell your doctor if you suffer from breathing difficulty associated with fever or cough, severe
diarrhea, loss of appetite, nausea or vomiting, severe blistering or peeling of skin, severe pain in
abdomen, acute or increasing pain and redness in eye, blurred vision or sensitivity to light,
increased eye watering.
For more information visit us: Erlocip 150mg